Recommended

New webinar with Fujifilm: Monocyte activation test (MAT): Insight into examining regulations and markets prospects
New webinar: The path to optimisation in pharmaceutical microbiology
Join our webinar: An alternative medium to support sterility testing using the Growth Direct® Rapid Sterility System
Discover more in our new application note: validating recombinant cascade reagents in 3 simple steps

List view / Grid view

Chemometrics

 

Kaiser Optical Systems - expert partners in Raman
Kaiser Optical Systems - expert partners in Raman
article

Kaiser Optical Systems: Expert partners in Raman

20 March 2018 | By

Kaiser Optical Systems provides Raman analysers and fibre-optic probes for pharmaceutical applications ranging from laboratory discoveries to process control. Working with Kaiser is an opportunity to benefit from its experience and knowledge in Raman spectroscopy, chemometric model development, bioprocessing and pharmaceutical analysis.

Francisca Gouveia, 4Tune Engineering Ltd
Francisca Gouveia, 4Tune Engineering Ltd
article

Pharma development and manufacturing with QbD 2.0

3 July 2014 | By José Menezes, Institute of Biotechnology and Bioenginerring, IST, Universidade de Lisboa / Francisca Gouveia and Pedro Felizardo, 4Tune Engineering Ltd

Pharma and BioPharma industries are aware of the impact of production processes on sustainability of business operations. To improve performance, companies have recognised that it is necessary to better understand the drivers of both costs and revenues and the actions that can be put in place to address them.

Chemometrics: Implementing multivariate data analysis to monitor mammalian cell culture processes
Chemometrics: Implementing multivariate data analysis to monitor mammalian cell culture processes
article

Chemometrics: Implementing multivariate data analysis to monitor mammalian cell culture processes

13 June 2013 | By Payal Roychoudhury, formerly AstraZeneca and Ronan O’Kennedy, Fujifilm Diosynth Biotechologies and Jim Faulkner, GlaxoSmithKline and Brian McNeil & Linda M. Harvey, University of Strathclyde

Biopharmaceutical companies are constantly evaluating new methods for mammalian cell line development that offer benefits such as shorter time lines, improved consistency, higher monoclonal antibody (mAb) production, better genetic stability and increased flexibility. Each of these advantages extends a potentially large cost benefit to companies as their recombinant protein products…

Pills
Pills
article

Intelligent Process Condition Monitoring for industrial tablet coating operation

18 December 2012 | By Jun Huang, Saly Romero-Torres, Liam Ryan and Mojgan Moshgbar, Pfizer Inc

This paper presents a feasibility study to develop an Intelligent Process Condition Monitoring (IPCM) system for providing a real time ‘health check’ for the tablet coating process in drug product manufacturing. The study fits well under the framework of Intelligent based Manufacturing (IbM) initiated at Pfizer, and intends to move…

Implementing chemometrics in late stage development and manufacturing
Implementing chemometrics in late stage development and manufacturing
article

Implementing chemometrics in late stage development and manufacturing

26 April 2012 | By Geir Rune Flåten, former Chemometrician Leader in Global Manufacturing and Supply at GlaxoSmithKline

Chemometrics was defined as a research area in 1974 and developed rapidly through the following decades in parallel with the fast paced improvement in analytical technologies and computational power for lab instruments and sensors. Chemometrics is essentially the translation of measured signals characterising a sample or a process into meaningful…